transcatheter aortic valve implantation

ACC.12 Highlights for Surgeons

ACC.12 Highlights for Surgeons | Conference Coverage

New research was recently presented at ACC.12, the annual scientific meeting of the American College of Cardiology, from March 24-27 in Chicago. The features below highlight just some of the studies that emerged from the meeting that pertain specifically to the surgeon audience. 

>> Positive Outcomes Observed With TAVI
>> Assessing the Safety of On- & Off-Pump CABG
>> TAVR Comparable to Open-Heart Surgery at 2 Years
>> Bariatric Surgery Yields Big Rewards for Obese Diabetics
>> Underweight Patients at Increased Risk During ICD Procedures
>> Improving the Quality of ACS Care  
   
Positive Outcomes Observed With TAVI

The Particulars: Transcatheter aortic valve implantation (TAVI) involves insertion of a bioprosthetic valve into a diseased native aortic valve and represents a potentially less invasive option than surgical replacement.…

Treating Degenerated Bioprosthetic Heart Valves | Conference Coverage

Valve-in-valve transcatheter aortic valve implantation (viv-TAVI) in patients with degenerated, surgically implanted bioprosthetic heart valves appears to achieve high technical success rates, according to findings from an international analysis. The viv-TAVI procedure also resulted in acceptable valvular function and excellent functional improvement.…

Examining TAVI With & Without PCI | Conference Coverage

A small German investigation has found that preprocedural PCI in patients undergoing transcatheter aortic valve implantation (TAVI) appears to be both feasible and safe. When compared with isolated TAVI, PCI plus TAVI resulted in decreased mortality rates. Both treatment strategies had similar rates of 30-day stroke, major bleeding, major vascular complications, and adverse events at 6 months.…